Literature DB >> 6444667

Cardiac septal hypertrophy in hyperinsulinemic infants.

J A Breitweser, R A Meyer, M A Sperling, R C Tsang, S Kaplan.   

Abstract

One infant with nesidioblastosis, and five of 18 infants of diabetic mothers had echocardiographically determined septal hypertrophy (greater than or equal to 6 mm). No correlation was found between the septal hypertrophy and the presence of hypocalcemia, polycythemia, birth asphyxia, or other observed clinical findings. All of the infants with septal hypertrophy, however, had profound hypoglycemia shortly after birth in contrast to those infants without septal hypertrophy. Macrosomic IDM have intrauterine hyperglycemia and hyperinsulinemia. The presence of profound neonatal hypoglycemia is consistent with the metabolic effects of significant neonatal hyperinsulinemia which is also present in the fetus. Infants with nesidioblastosis also have fetal hyperinsulinemia. Recent investigations have suggested an important role for insulin in the developing heart since it is rich in insulin receptors and contains marked insulin degrading capacity. Although fetal hyperglycemia has been suggested as the cause of septal hypertrophy in IDM, we hypothesize that fetal hyperinsulinemia contributes directly to the spinal hypertrophy.

Entities:  

Mesh:

Year:  1980        PMID: 6444667     DOI: 10.1016/s0022-3476(80)80862-6

Source DB:  PubMed          Journal:  J Pediatr        ISSN: 0022-3476            Impact factor:   4.406


  23 in total

1.  Follow up of a randomised trial of two different courses of dexamethasone for preterm babies at risk of chronic lung disease.

Authors:  D L Armstrong; J Penrice; F H Bloomfield; D B Knight; J A Dezoete; J E Harding
Journal:  Arch Dis Child Fetal Neonatal Ed       Date:  2002-03       Impact factor: 5.747

2.  Outcome of fetuses with heart disease diagnosed in utero.

Authors:  M Eronen
Journal:  Arch Dis Child Fetal Neonatal Ed       Date:  1997-07       Impact factor: 5.747

3.  Unusual association of hypertrophic cardiomyopathy with complete atrioventricular canal defect and Down syndrome.

Authors:  B W Eidem; C Jones; F Cetta
Journal:  Tex Heart Inst J       Date:  2000

Review 4.  Clues in diagnosing congenital heart disease.

Authors:  A J Moss
Journal:  West J Med       Date:  1992-04

5.  Cardiac effects of short course dexamethasone in preterm infants.

Authors:  R Skelton; A B Gill; J M Parsons
Journal:  Arch Dis Child Fetal Neonatal Ed       Date:  1998-03       Impact factor: 5.747

6.  A syndrome of insulin resistance resembling leprechaunism in five sibs of consanguineous parents.

Authors:  L I al-Gazali; M Khalil; K Devadas
Journal:  J Med Genet       Date:  1993-06       Impact factor: 6.318

7.  Cardiac hypertrophy secondary to ACTH treatment in children.

Authors:  D Lang; E Mühler; C Kupferschmid; E Tacke; G von Bernuth
Journal:  Eur J Pediatr       Date:  1984-06       Impact factor: 3.183

8.  Sequential longitudinal evaluation of cardiac growth and ventricular diastolic filling in fetuses of well controlled diabetic mothers.

Authors:  H S Weber; J J Botti; B G Baylen
Journal:  Pediatr Cardiol       Date:  1994 Jul-Aug       Impact factor: 1.655

9.  Hypertrophic cardiomyopathy in neonates with congenital hyperinsulinism.

Authors:  TingTing Huang; Andrea Kelly; Susan A Becker; Meryl S Cohen; Charles A Stanley
Journal:  Arch Dis Child Fetal Neonatal Ed       Date:  2013-02-01       Impact factor: 5.747

10.  Cardiomyopathy in offspring of diabetic rats is associated with activation of the MAPK and apoptotic pathways.

Authors:  Benjamin E Reinking; Elesa W Wedemeyer; Robert M Weiss; Jeffrey L Segar; Thomas D Scholz
Journal:  Cardiovasc Diabetol       Date:  2009-07-31       Impact factor: 9.951

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.